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Several designs and analytical approaches have been proposed to dissect oﬀspring from maternal genetic contributions to early-
onsetdiseases.However,lackofparentalcontrolshaltsthedirectveriﬁcationoftheassumptionofmatingsymmetry(MS)required
to assess maternally-mediated eﬀects. In this study, we used simulations to investigate the performance of existing methods
under mating asymmetry (MA) when parents of controls are missing. Our results show that the log-linear, likelihood-based
frameworkusingacase-triad/case-controlhybriddesignprovidesvalidtestsformaternalgeneticeﬀectsevenunderMA.Usingthis
approach,weexaminedfetomaternalassociationsbetween29SNPsin12cell-cyclegenesandchildhoodpre-Bacutelymphoblastic
leukemia (ALL). We identiﬁed putative fetomaternal eﬀects at loci CDKN2A rs36228834 (P = .017) and CDKN2B rs36229158
(P = .022) that modulate the risk of childhood ALL. These data further corroborate the importance of the mother’s genotype on
the susceptibility to early-onset diseases.
1.Introduction
The risk for early-onset disorders can be inﬂuenced both by
the inherited genotype of the child as well as by parentally-
mediated genetic eﬀects [1]. The mother has a crucial
role in early-onset disease predisposition as she provides
the prenatal environment [2, 3] and can inﬂuence her
oﬀspring’s risk of disease not only as a genetic donor but
also through the eﬀects of her genes acting directly on
the intrauterine milieu or indirectly through fetomaternal
gene-gene interactions [1, 4–6]. Given the important role
the mother can play in shaping disease susceptibility in
her oﬀspring, focusing solely on the genotype of the
child in association testing could, in certain instances, be
misleading.
Several family-based tests have been proposed to
dissect oﬀspring and maternal genetic contributions to
early-onset disorders including the case-parent designs of
Wilcox et al. [1] and Weinberg et al. [3] using a log-linear
framework, and of Cordell et al. [7, 8], which uses a
conditional logistic regression framework. Designs using
alternative family structures have also been suggested: the
hybrid design based on augmenting a set of case-parent trios
with a set of parents of unrelated controls [9], the “pent”
design consisting of the aﬀected child, mother, father, and
maternal grandparents [2], the case-mother/control-mother
dyad design [10] or the design consisting of case-parent
triads supplemented by control-mother dyads [11]. How-
ever, the use of these alternative designs can be limited by
the diﬃculty of obtaining grandparental data or suﬃciently2 Journal of Biomedicine and Biotechnology
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Figure 1: Cohort data used for simulations. 200 replicate datasets
were generated for each model. For all of our calculations we used
t h es a m eo v e r a l ln u m b e ro fa ﬀected individuals and case-parents
however themethodsdiﬀered inhowthecaseand controldatawere
utilized in each individual test (see Materials and Methods). The
same number of aﬀected individuals (n = 330) and case-parents
(n = 400) was used under all three methods. For the combined
case-control and conditional logistic regression analysis (CC+CLR)
andthelog-linearanalysisusingunrelatedcontrolsratherthantheir
parents (HD-NPC), we used the genotypes of unrelated controls
(n = 325, in blue), whereas for the hybrid design using parents
of controls in a log-linear framework (HD), we incorporated the
genotypic information of the parents of these controls rather than
the controls themselves (n = 650, in red).
large samples of parents of unaﬀected children, and by the
increaseincostsincurredforgenotypingtheseadditionalsets
of individuals. On the other hand, in many ongoing genetic
association studies it often occurs that parents of cases and
unrelated control individuals are collected in parallel, in
which case designs based solely on case-triad data could
lead to considerable losses in power if unrelated case-control
data are disregarded. In the event that both case-parent
triads as well as case-control data are ascertained, additional
designs/analytical strategies are needed for fetomaternal
genotype association testing.
Theﬁrstaimofthisstudywastoevaluatetheadaptability
of existing methods to deal with mixed data sets consisting
of both case-parent triads and case-control data. We used
simulations to investigate the validity and power of (1)
Weinberg and Umbach’s hybrid design [9] treating parents
of controls as missing (HD-NPC) and (2) a classic case-
control test in conjunction with Cordell et al.’s conditional
logistic regression method [7] (CC+CLR), to distinguish
between oﬀspring and maternal genetic contributions to
disease. Given that Cordell et al.’s approach relies solely on
theuseofcase-parenttriads,combiningitwithacase-control
test will allow us to maximize the use of available genotype
information. Finally, we compared both these approaches to
a third hypothetical, ideal situation, in which genotype data
from parents of controls would be available and Weinberg
andUmbach’shybriddesigncouldbeused(HD)asdescribed
in [9].
However lack of parents of controls in HD-NPC and
CC+CLR precludes the direct veriﬁcation of the assump-
tion of mating symmetry (MS) that is required to assess
maternally-mediated eﬀects. Mating symmetry (MS) refers
to the hypothesis that for a parental genotype pair, the fre-
quency in the population for a given mother-father genotype
assignment is the same as for the reverse father-mother
assignment [1, 12]. Departures from this symmetry could
lead to genotype frequency diﬀerences among males and
females mating in the population which, in the context of
fetomaternal association testing, could lead to confound-
ing and spurious maternal associations. As such, the HD
approach, using an auxiliary sample of parents of controls
to obtain direct information on mating frequencies [9], is
the only method that allows for the assumption of symmetry
to be directly tested and readily accommodated. It is unclear
howeverhowthismethodperformswhenparentsofcontrols
are missing and MA is present. And since parents of
unaﬀectedcontrolsarenotavailableinmostongoingstudies,
it is important to assess the robustness of these fetomaternal
association tests under such circumstances. Therefore, we
evaluated type I error rates and power of the three methods
(HD, HD-NPC, and CC+CLR) under varying degrees of
MA, and genotypic risk models involving child, mother
or both child and mother jointly, in order to identify the
analytical approach that is most reliable for dissecting child
and maternal genetic contributions to early-onset diseases in
the absence of parents of controls.
Another aim of this study was to use these methods
to investigate fetomaternal associations in a real mixed
dataset of childhood pre-B acute lymphoblastic leukemia
(ALL) patients. ALL is a hematological malignancy resulting
from chromosomal alterations and mutations that aﬀect
molecular pathways that disrupt lymphoid progenitor cell
diﬀerentiation[13,14].Thereiswell-establishedevidencefor
prenatal initiation of the leukemogenesis process in children
[15–18]. Moreover, parental exposures to environmental
carcinogens or use of medication have been identiﬁed as
potential risk factors for childhood leukemia [19–23]a n d
transplacental carcinogen exposure has been involved in the
development of certain subtypes of ALL [24]. Although the
riskofleukemiafromenvironmentalexposuresinuteroorin
early childhood is likely to be inﬂuenced by genetic variation
at both the level of the child and the mother, the role of
maternally-mediated genetic eﬀects in childhood leukemia
susceptibility remains undeﬁned. Here we performed a
candidate gene association study using both ALL case-parent
triads and unrelated controls to assess the impact of 29
SNPs from 12 cell-cycle genes in both mother and child on
childhood pre-B ALL risk.
2.MaterialsandMethods
2.1. Methods Used to Test for Fetomaternal Genotype Asso-
ciations. We compared three analytical approaches for the
detection of early-onset disease associations. In the event
that both case-parent triads and unrelated case-control data
are available, we tested (1) a combined method in which a
case-control genotypic test was carried out in conjunction
with the conditional logistic regression test of Cordell et
al. to detect associations at the level of the child and
mother, respectively (CC+CLR); and (2) the log-linear,
likelihood-based approach of Weinberg and Umbach [9]Journal of Biomedicine and Biotechnology 3
Table 1: Forward stepwise likelihood-ratio testing procedure used to dissect child and maternal genotype associations.
Weinberg and Umbach’s log-linear approach using case-triads,
unrelated cases and unrelated controls (HD-NPC) or parents of
controls (HD)
Genotypic case-control test combined with the conditional logistic
regression approach of Cordell et al. using case-triads (CC+CLR)
Step 1. Step 1.
Child genotypic eﬀect Child genotypic association test (CC)
Null versus CG LR Chi-square (2df) Chi-square or Fisher’s exact test (2df)
And And
Maternal genotypic eﬀect Maternal genotypic eﬀect (CLR)
Null versus MG LR Chi-square (2df) Null versus MG LR Chi-square (2df)
Step 2. (depending on Step 1) Step 2. (depending on Step 1)
Maternal eﬀect given child eﬀect Maternal eﬀect given child eﬀect (CLR)
CG versus CG+MG LR Chi-square (2df) CG versus CG+MG LR Chi-square (2df)
Or Or
Child eﬀect given maternal eﬀect Child eﬀect given maternal eﬀect (CLR)
MG versus CG+MG LR Chi-square (2df) MG versus CG+MG LR Chi-square (2df)
Likelihood-ratio tests were performed in a forward stepwise fashion. The most signiﬁcant single-step test (Child versus Null or Mother versus Null) was tested
against a joint eﬀects model in a 2 degree-of-freedom likelihood-ratio test (Child + Mother versus Child or Child + Mother versus Mother). LR Chi2 indicates
likelihood-ratio chi-square test; df, degrees of freedom; GC Child genotype relative risk; GM, Mother genotype relative risk.
Table 2: The eight simulation models used for evaluation of the fetomaternal association tests.
Model Child eﬀect Mother eﬀect MAF ΔC
1 — — 0.05 to 0.25 MS
2G C 11 = 1; GC12 = 2; GC22 = 3 — 0.05 to 0.25 MS
3— G M 11 = 1; GM12 = 2; GM22 = 3 0.05 to 0.25 MS
4G C 11 = 1; GC12 = 2; GC22 = 3G M 11 = 1; GM12 = 2; GM22 = 3 0.05 to 0.25 MS
5— — 0 . 3 0 t o 1
6G C 11 = 1; GC12 = 2; GC22 = 3— 0 . 3 0 t o 1
7— G M 11 = 1; GM12 = 2; GM22 = 30 . 30 t o 1
8G C 11 = 1; GC12 = 2; GC22 = 3G M 11 = 1; GM12 = 2; GM22 = 30 . 30 t o 1
(–): indicates a null risk model where the genotype relative risks (GRRs) are GRR11 = GRR12 = GRR22 = 1. GC indicates Child genotype relative risk; GM,
Mother genotype relative risk; MAF: Minor allele frequency; ΔC: mating-pair disequilibrium. MS indicates mating symmetry where ΔC = 0.
using an additional set of unrelated cases and unrelated
controlsasproxiesforparentalcontrolgenotypeinformation
(HD-NPC). We also compared these two approaches to
(3) one in which parents of controls are also available and
therefore the hybrid design (case-parent/parents of controls)
can be used through log-linear, likelihood-based analysis
(HD).
It should be noted that the combined CC+CLR approach
is not a modiﬁcation of the conditional logistic regression
approach of Cordell et al. but rather an adaptation in
its use to detect fetomaternal associations. Cordell et al.’s
approach relies solely on the use of case-parent triads. Since
disregarding any available unrelated case-control genotype
data reduces power, we used Pearson’s chi-square tests or
Fisher’s exact tests (CC), as appropriate, and conditional
logistic regression (CLR) in parallel on partially overlapping
data. The former were used on all available cases to identify
genotype associations at the level of the child whereas the
latter was used on case-parent triads to identify maternally-
contributed eﬀects. Results from the two tests were not
combined, rather if a signiﬁcant association was found in the
child CC test then the CLR test was used (albeit on a reduced
case set) in order to dissect oﬀspring and maternal eﬀects.
Similarly, if a signiﬁcant result was found for the mother
test using CLR, then CLR was further used to distinguish a
main eﬀect of the mother from a joint fetomaternal eﬀect
(see likelihood-ratio testing below).
2.2. Likelihood-Ratio Testing to Dissect Child from Maternal
Genetic Eﬀects. Given that the oﬀspring will be enriched
for the risk allele by simple Mendelian inheritance [25],
it is important to discriminate between direct eﬀects of
a maternal genotype or of a child genotype from a joint
fetomaternal eﬀect. To do so, we used a forward stepwise
likelihood-ratio testing procedure. In the ﬁrst step, we
performed two single-step tests to investigate associations
at the level of the child and mother separately (Table 1).
For CC+CLR, Pearson’s chi-square or Fisher’s exact tests
were performed in R (version 2.6.2), to compare genotype
distributions in cases (unrelated and triad cases) versus
controls. In parallel, we used case-parent triads and logistic4 Journal of Biomedicine and Biotechnology
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Figure 2: Type I error rates and power for the maternal association test under mating asymmetry. (a) Type I error rates are given for the
Mother versus Null test as a function of departure from mating symmetry, as measured by ΔC, under the null model where GC11 = GC12 =
GC22 = GM11 = GM12 = GM22 = 1( Table 2,M o d e l5 ) .A l l e l ep r e v a l e n c ei ss e ta tq = 0.3. (b) Power to detect a maternal eﬀect is shown as a
function of departure from mating symmetry, as measured by ΔC, for a scenario with multiplicative eﬀects of the mother (Table 2,M o d e l
7). Allele prevalence is set at q = 0.3. MA models (9 mating-type parameters) were used for log-linear regression under the assumption of
mating asymmetry. Horizontal reference lines indicate type I error rate of α = 0.05 (a) and power = 0.8 (b). HD: hybrid design using parents
of controls in a log-linear framework; HD-NPC: log-linear analysis using unrelated controls rather than their parents; CC+CLR: combined
case-control and conditional logistic regression analysis.
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Figure 3: Power of the forward stepwise procedure to detect joint fetomaternal associations. (a) Power for the HD, HD-NPC and CC+CLR
methods is shown as a function of allele prevalence for a scenario with mating symmetry and multiplicative eﬀects of both Child and
Mother (Table 2, Model 4). (b) Power for HD and HD-NPC is shown as a function of departure from mating symmetry, as measured by
ΔC, for a scenario with mating asymmetry and multiplicative eﬀects of both Child and Mother (Table 2,M o d e l8 ) .A l l e l ep r e v a l e n c ei ss e ta t
q = 0.3. MA models (9 mating-type parameters) were used for log-linear regression under the assumption of mating asymmetry. Horizontal
reference lines indicate power = 0.8. HD, hybrid design using parents of controls in a log-linear framework; HD-NPC: log-linear analysis
using unrelated controls rather than their parents; CC+CLR: combined case-control and conditional logistic regression analysis.Journal of Biomedicine and Biotechnology 5
Table 3: Parental genotype distributions under mating symmetry
and mating asymmetry.
Mating type
Parental genotypes Expected distribution
(Mother-Father) Mating
symmetry
Mating
asymmetry
0 11-11 N ∗μ0 N ∗μ0
1
11-12 N ∗μ1 (2 −C1)∗N∗μ1
12-11 N ∗μ1 C1 ∗N ∗μ1
2
11-22 N ∗μ2 (2 −C2)∗N∗μ2
22-11 N ∗μ2 C2 ∗N ∗μ2
3 12-12 N ∗μ3 N ∗μ3
4
12-22 N ∗μ4 (2 −C4)∗N∗μ4
22-12 N ∗μ4 C4 ∗N ∗μ4
5 22-22 N ∗μ5 N ∗μ5
Alleles for a biallelic locus are denoted 1 and 2 and the corresponding
genotypes 11, 12 or 22. N indicates the number of individuals in the
sample; μi the ith mating type probability under the assumption of random
mating; Ci the mating-pair disequilibrium for the ith parental couple.
C is a multiplicative factor between 0 and 2 that describes the over
representation (>1), under representation (<1) or symmetry (=1) of a mate-
pair combination in the corresponding ith mating type.
regression conditioning on exchangeable parental genotypes
(CEPG) [7, 8], using the DGCgenetics package for R
developed by D. Clayton (available at http://www-gene.cimr
.cam.ac.uk/clayton/software/DGCgenetics 1.0.tar.gz)t ot e s t
for maternally-mediated associations through a two degree-
of-freedom likelihood-ratio test (Mother versus Null). For
HD-NPC and HD, log-linear regression analysis was per-
formed using the LEM software (Log-linear and event
history analysis with missing data using the EM algo-
rithm) [26] and LEM script ﬁles provided by Wein-
berg et al. (available at http://www.niehs.nih.gov/research/
resources/software/hybrid/index.cfm)[ 9, 26]. Two degree-
of-freedom likelihood-ratio tests were performed to inde-
pendently test for oﬀspring (Child versus Null) and maternal
(Mother versus Null) associations in the log-linear frame-
work.
In the second step, if a signiﬁcant eﬀect was found in the
ﬁrst step (based on a Bonferroni correction of P<. 025 for
the 2 tests performed), then the most signiﬁcant model was
tested against a joint eﬀects model (Child + Mother versus
Child or Child + Mother versus Mother) in a two degree-
of-freedom likelihood-ratio test (Table 1). For CC+CLR this
meant that conditional logistic regression was used on the
reduced case-triad data set to test either Child + Mother
versus Child or Child + Mother versus Mother depending
on the results from step one. Whereas log-linear regression
analysis was performed on case-triads and unrelated cases
and controls in HD-NPC and on case-triads, unrelated cases
and parents of controls in HD.
2.3.SimulatedData. We simulated cohortdata underseveral
conditions to model diﬀerent genotypic risk eﬀects involving
either child, mother or both child and mother (joint feto-
maternal eﬀects) (Table 2). Under each model 200 replicate
datasets were simulated using the R software. Replicates
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Figure 4:TypeIerrorratefortheHDandHD-NPCapproachesfor
the maternal association test assuming either mating symmetry or
asymmetry. Type I error rates are shown as a function of departure
from mating symmetry, as measured by ΔC, under the null model
where GC11 = GC12 = GC22 = GM11 = GM12 = GM22 = 1( Table 2,
Model 5). Allele prevalence is set at q = 0.3. Log-linear, likelihood-
based testing (Mother versus Null) was performed assuming either
mating asymmetry estimating nine mating-type parameters in the
likelihood-ratio tests (Asym), or mating symmetry using only
six mating-type parameters in the likelihood-ratio tests (Sym),
or with no a priori hypothesis, using a 3 degree-of-freedom
likelihood-ratiotesttoﬁrsttesttheassumptionofmatingsymmetry
(MatingAsymmetry(9df)versusMatingSymmetry(6df))andthen
using either the mating asymmetry models when asymmetry was
detected or the mating symmetry models when it was not (Mixed).
Horizontal reference line indicates type I error rate of α = 0.05. HD,
hybrid design using parents of controls in a log-linear framework;
HD-NPC, log-linear analysis using unrelated controls rather than
their parents.
that did not ﬁt the simulated models were not included
in the analysis. To imitate our childhood leukemia cohort,
we simulated genotypic data for 200 case-parent triads, 130
unrelated cases and 325 unrelated control-parent triads for
each replicate. For all of our calculations we used the same
overall number of aﬀected individuals however the methods
diﬀeredinhowthecaseandcontroldatawereutilizedineach
individual test (Figure 1). For all of our child-based tests we
used the same number of aﬀected individuals and unrelated
controls (Figure 1): 330 cases (200 case-triads and 130
unrelated cases) were compared to 325 unrelated controls.
However the number of cases and population-based controls
usedformaternalandfetomaternalassociationtestingvaried
depending on the method: CC+CLR used the genotypes
from 200 case-triads only; HD-NPC used the genotypes of
330 cases (200 case-triads and 130 unrelated cases) and of
325 unrelated controls; and HD incorporated the genotypic
information of the parents (n = 650) rather than the
unrelated controls themselves (Figure 1).
In HD and HD-NPC, unrelated cases and controls were
used by treating their parental genotypes as missing and the6 Journal of Biomedicine and Biotechnology
EM algorithm implemented in the LEM software was used
to infer missing genotype information [26]. Unrelated cases
and cases belonging to triads were considered to have similar
penetrance and thus similar genotypic relative risks (GRR).
We assumed Hardy-Weinberg equilibrium and the absence
of population stratiﬁcation in the form of admixture. We
evaluated the diﬀerent approaches in terms of type I error
rateandpowertodetectassociationsbycountingthenumber
ofreplicatesfoundtobesigniﬁcantlyassociatedoverthetotal
number of replicates that ﬁt the speciﬁed model.
2.4. Simulated Scenarios. We ﬁrst assessed the behaviour of
the three methods in scenarios in which MS was assumed
across parents. Under MS, HD-NPC and HD were per-
formed by forcing six mating-type variables in the log-linear
model [9].
A second set of simulations was performed in which we
assessed the performance of the tests assuming diﬀerences in
genotype frequencies between males and females mating in
the population, that is, assuming varying levels of mating
asymmetry. MA was evaluated in terms of the degree of
departure from the expected mate-pair probability under
symmetry. We used Ci to denote the disequilibrium for the
ith parentalmating type. Ci is a multiplicative factorbetween
0 and 2 that describes the over representation (C>1), under
representation (C<1) or symmetry (C = 1 )o fam a t e -
pair combination in the corresponding ith mating type. The
level of departure from MS is denoted as ΔC, a numerical
value ranging from −1t o1 ,w i t hC = 1+ ΔC.T h ee x p e c t e d
parental genotype distributions under the assumption of MS
and MA are shown in Table 3. By varying the departure
from mating symmetry, ΔC, we introduced varying levels
of asymmetry into our simulations (Table 2). In this study
we assumed a model for MA where C1 = C2 and C4 =
1. Supplementary Figure 1, mentioned in Supplementary
Material that is available online at doi: 10.1155/2010/369534,
shows how departures from symmetry, as measured by ΔC,
translate into diﬀerences in reciprocal mating types and
overall genotype frequencies between males and females
mating in the population. Under MA, HD-NPC and HD
were performed by forcing nine mating-type variables in
the log-linear model [9] and we tested for the presence of
asymmetry by comparing the nine mating-type model to
the six mating-type model with a three degree-of-freedom
likelihood-ratio test using a cut-oﬀ of P<. 05 to declare
deviation from symmetry. A less conservative P value <.10
was also used (data not shown) and yielded similar results.
2.5. Childhood Acute Lymphoblastic Leukemia Data
2.5.1. Study Subjects. We investigated fetomaternal associa-
t i o n si nap r e - Ba c u t el y m p h o b l a s t i cl e u k e m i a( A L L )c o h o r t .
Thestudypopulation hasbeenpreviouslydescribed[27,28].
Brieﬂy, incident cases of childhood pre-B ALL (n = 321)
were diagnosed in the Division of Hematology-Oncology of
the Sainte-Justine Hospital in Montreal, Canada, between
October 1985 and November 2006. Our cohort includes
189 boys and 132 girls with a median age of 4.7 years,
all French-Canadian from the province of Quebec, Canada.
Parental DNA was available for 203 of the probands.
Healthy controls (n = 329) consisted of French-Canadian
individuals recruited while using clinical departments other
than Hematology-Oncology of the Sainte-Justine Hospital.
2.5.2. SNPs, Genotyping and Quality Control Checks. We
selected 29 SNPs from 12 candidate cell-cycle genes for the
analysis (Table 4). Genes were selected based on their func-
tion in regulating the G1/S cell-cycle checkpoint. Regulatory
SNPs (found to lie within the proximal promoter region)
were chosen based on the hypothesis that variation in gene
dosage of such critical cell-cycle genes due to functional
regulatory polymorphisms could inﬂuence cancer suscepti-
bility by altering cell homeostasis [28]. For the purpose of
this study using a French-Canadian cohort, we considered
European-speciﬁc SNPs previously identiﬁed in [29]. DNA
was isolated from buccal epithelial cells, peripheral blood
or bone marrow in remission as previously described [30].
SNPs were genotyped using the Luminex xMAP/Autoplex
Analyser CS1000 system (Perkin Elmer, Waltham, MA).
Genetic variants were ampliﬁed using allele-speciﬁc primer
extension in multiplexed assays and hybridized to Luminex
MicroPlex TM –xTAG Microsperes as per Koo et al. [31].
Primer sequences, ampliﬁcation conditions, and reaction
conditions are available upon request. Genotypes were called
using the Automatic Luminex Genotyping (ALG) software
[32]. Three negative controls and three sample duplicates
were used on each 96-well DNA plate. The average genotype
call rate was 99.8% and rates of discordance were below
3.3%. In addition, Hardy-Weinberg equilibrium was tested
using the X2 goodness of ﬁt test and PedCheck (Version
1.1) was used to identify genotype incompatibilities using
the familial data [33]; inconsistent case-parent trios were
removed from the analyses. Multiple testing corrections
were performed on the single-step association tests using
the Benjamini-Hochberg false discovery rate (FDR) method
with a type I error rate of 10%; nominal P values are shown.
3. Results and Discussion
Although there are currently no data to document the
frequency of events that lead to mating distortions in
human populations, it is biologically plausible that MA
might commonly occur. It is known that assortative mating
(selection of a mate on the basis of phenotype leading to
correlation between phenotypes of mated individuals with
respect to a given trait) can lead to genotype frequency
diﬀerences between males and females [34–36].Othermech-
anisms leading to mating asymmetry however are unclear
and their evolutionary consequences much less understood.
I f ,f o ras p e c i ﬁ cm a r k e r ,M Ar e s u l t si nad e p a r t u r ef r o m
Hardy-Weinberg equilibrium, this genetic marker would be
excludedfromanassociationstudyfollowingqualitycontrol.
However MA could also arise through mating selection but
withdiscrimination acting oppositely in eachsex, or through
diﬀerential individual mating success for the genotypes
of each sex. Both these processes could lead to genotypeJournal of Biomedicine and Biotechnology 7
Table 4: Genes and DNA variants genotyped in the pre-B ALL
association study.
Gene
(Chromosme) DNA variant Position MAF
CCND1 (11q13)
rs1944129 69,163,116 0.4876
rs36225395 69,163,517 0.4523
CDC25a (3p21)
rs1903061 48,206,923 0.1028
CDKN1A (6p21)
rs733590 36,753,181 0.3616
rs762624 36,753,566 0.2714
rs2395655 36,753,674 0.3968
CDKN1B (12p13)
rs3759217 12,759,719 0.1159
rs35756741 12,759,968 0.0865
rs36228499 12,761,203 0.4342
CDKN2A (9p21)
rs36228834 21,965,319 0.0512
CDKN2B (9p21)
rs36229158 22,000,681 0.0282
rs2069416 22,000,004 0.3742/0.0271
rs2069418 21,999,698 0.4272
E2F1 (20q11)
rs3213141 31,738,041 0.2405
HDAC1 (1p35)
rs1741981 32,529,026 0.3302
rs36212121 32,529,102 0.0031
rs36212119 32,529,840 0.0846
MADH3 (15q22)
rs36221701 65,143,543 0.1199
rs36222034 65,144,732 0.1111
rs11633026 65,144,812 0.1235
MDM2 (12q15)
rs1144944 67,486,752 0.4954
rs3730485 67,487,073–
67,487,112 0.4052
rs937282 67,488,064 0.483
rs2279744 67,488,847 0.3662
RB1 (13q14)
rs1573601 47,774,358 0.2484
TGFB1 (19q13)
rs2317130 46,553,514 0.3141
rs4803457 46,553,199 0.3937
rs11466313 46,553,177–
46,553,178 0.3096
rs1800469 46,552,136 0.3127
DNA variant positions relative to dbSNP build 130. MAF indicates minor
allele frequency and was calculated on a control cohort consisting of 329
healthy individuals of European descent.
frequency diﬀerences between sexes that would not lead to
detectable deviations from Hardy-Weinberg equilibrium but
that may incur important biases in fetomaternal association
testing. In addition to these biological causes, low levels of
MA could arise in a study sample simply due to the sampling
process. Although parents of controls allow direct testing
for bias due to MA in fetomaternal genotype association
testing [9], these samples are diﬃcult to collect and a
methodthatcancombinecase-controlandfamily-baseddata
and provide a valid analytical framework for fetomaternal
association testing in the presence of MA is currently not
available.
3.1. Simulation Study. In this study we used simulations to
investigate the ability of three fetomaternal genotype asso-
ciation tests: (1) the log-linear, likelihood-based method of
Weinberg and Umbach [9] using a case-parent/case-control
design (HD-NPC), (2) the conditional logistic regression
approach of Cordell et al. [7] combined with a case-control
test (CC+CLR), and (3) Weinberg and Umbach’s hybrid
design using log-linear regression analysis, to distinguish
between oﬀspring and maternal genetic contributions to
disease in the presence of MA. It should be noted that
since both the log-linear and CLR frameworks are equivalent
i nt e r m so fp o w e ra n dt y p eIe r r o rf o rt h ed e t e c t i o no f
maternal genotype eﬀects [7], our conclusions regarding
the CC+CLR approach would also apply to a case-control
combined with the log-linear linear framework of Wilcox
et al. [1] and Weinberg et al. [3] using case-parent triads. We
evaluated type I error rates and power of the methods under
varying degrees of MA, and genotypic risk models involving
child, mother or joint eﬀects of both child and mother
(Table 2). For clarity reasons, we present the results for
multiplicative genotype eﬀect models only. However similar
results were obtained under dominant and recessive models,
with recessive models yielding expected decreases in power
across all methods, particularly at low allele frequencies.
As expected, all three methods showed similar low type
I error rates, around 5% and similar power, above 80% for
the detection of child eﬀects (GC11 = 1; GC12 = 2; GC22 = 3)
u n d e rM Sa sw e l la su n d e rM A( d a t an o ts h o w n ) .F o ra
maternal main eﬀect (GM11 = 1; GM12 = 2; GM22 = 3),
type I error and power under MS were also within the
acceptable ranges (data not shown). By contrast, under
MA the CC+CLR method yielded unacceptably high type I
error rates for the Mother test (Figure 2(a)). Although we
expected that the method developed by Cordell et al. would
be susceptible to the confounding incurred by MA, we found
that CLR does not withstand even low levels of asymmetry
(ΔC ∼ 0.1) so that even weak assumptions concerning
population distributions of parental genotypes could lead to
important bias.
The validity of the Mother tests for HD and HD-NPC
were unaﬀected by MA, with type I error rates below the
5% threshold (Figure 2(a)). Power of the HD design was
maintained at 100% and was unaﬀected by MA under
the simulation conditions considered here, whereas power
of HD-NPC considerably dropped, averaging around 30%
(Figure 2(b)). When HD-NPC is used under asymmetry,
genotypes for the parents of controls are inferred based on
mating-type frequencies estimated from the parents of the
casesandbasedontheassumptionsthatthecontroloﬀspring
genotypes follow Mendelian proportions in relation to their
parents [9]. Hence, the maternal eﬀect present in the case8 Journal of Biomedicine and Biotechnology
triads is partially captured in the inference of the mating-
type frequencies for the parents of controls, resulting in a
loss of power to detect this maternal eﬀect as it becomes
confounded with the estimated asymmetry.
The stepwise procedure allows maternal and case eﬀects
to be distinguished by estimating maternal eﬀects inde-
pendently of oﬀspring eﬀects and provides a valid test for
joint fetomaternal associations. Under the null model and
MS, the stepwise likelihood-ratio testing procedure yielded
type I error rates close to 0% (data not shown), most
likely due to the over-conservative Bonferroni correction
that was applied. Since the Mother and Child tests are
not completely independent a permutation test procedure
wouldprovide less-conservative type I errorestimates. When
we modelled multiplicative eﬀects of both oﬀspring and
maternal eﬀects (GC11 = GM11 = 2a n dG C 12 = GM12 =
3), the power to detect fetomaternal associations using the
forward stepwise procedure was comparable for all three
methods and increased with increasing allele prevalence for
each method, reaching 80% for MAFs > 0.20 (Figure 3(a)).
We then evaluated type I error rates and power for the
stepwise procedure in the presence of MA. The performance
of both HD and HD-NPC was unaﬀected by MA with type I
error rates close to zero even in the presence of high levels of
a s y m m e t r y( S u p p l e m e n t a r yF i g u r e2 ) .T h et y p eIe r r o rr a t e
of the CC + CLR approach was close to 5% (Supplementary
Figure 2) given that both child and maternal eﬀects had to
be falsely detected in order for the replicate to be counted
as a false-positive and the case-control component of the
test was robust against spurious child associations. Because
the CLR maternal test is not valid under even low levels
of MA, we assessed the power of the other two approaches
to detect fetomaternal associations for varying levels of MA
(Figure 3(b)). HD performed signiﬁcantly better than HD-
NPC: sensitivity of the HD design averaged around 100%
whereas power of HD-NPC was again signiﬁcantly lower,
averaging around 40%.
Based on the above ﬁndings, no method seemed to
provide a net advantage under MS for these simulation
conditions; nor did we observe any signiﬁcant loss of power
or robustness when the conditional logistic regression or
the log-linear, likelihood-based approaches were used with-
out parents of controls. Although power was signiﬁcantly
reduced, the log-linear, likelihood-based approach using
controls rather than parents had little eﬀect on the speciﬁcity
of the association tests in the presence of MA. However,
for the analyses performed on MA simulated datasets, we
forced the estimation of nine mating-type parameters. In
practice, no a priori assumptions regarding MS could be
made. To verify the robustness of both methods for the
detection of maternal (and fetomaternal) genotype eﬀects in
the presence of asymmetry, we measured type I error rates
for the Mother test for scenarios in which either MA or
MS models are assumed, and for a scenario in which no a
priori hypothesis is made but rather MS is ﬁrst evaluated
in a three degree-of-freedom likelihood ratio test and the
appropriate models (MA or MS) are subsequently used for
association testing. These results show that if one assumes
MS and this assumption is violated, type I error rates for
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Figure 5: Power of HD and HD-NPC to detect mating asymmetry.
Power is shown as a function of departure from mating symmetry,
as measured by ΔC, under the null model where GC11 = GC12 =
GC22 = GM11 = GM12 = GM22 = 1( Table 2, Model 5). Allele
prevalence is set at q = 0.3. Mating asymmetry was evaluated in the
log-linear framework using a 3 degree-of-freedom likelihood-ratio
test comparing the 9 mating-type parameter model under MA to
a 6 mating-type parameter model under MS. Horizontal reference
line indicates power = 0.8. HD: hybrid design using parents of
controls in a log-linear framework; HD-NPC: log-linear analysis
using unrelated controls rather than their parents.
the maternal test for both HD-NPC and HD are signiﬁcantly
inﬂated (Figure 4). However, ﬁrst testing for asymmetry and
then adjusting the association analyses accordingly provides
accurate type I error rates for both methods. Similar results
were obtained for the forward stepwise procedure (data not
shown).
The speciﬁcity of the HD-NPC test therefore relies on
its ability to detect MA and then use mating-type models
accounting for asymmetry to test for association. Given that
there are no biological references for the amount of MA
that occurs in human populations, we evaluated the capacity
of the HD and HD-NPC methods to detect various levels
of MA (Figure 5). Our simulation results showed that the
power of HD-NPC to detect asymmetry above ΔC = 0.4
was comparable to that of HD. For a risk allele frequency
of q = 0.3, HD and HD-NPC reached 80% power at
ΔC = 0.25 and ΔC = 0.35, respectively. Under low
levels (ΔC ranging from 0 to 0.2) the sensitivity of both
methods to detect asymmetry was threatened, especially for
the HD-NPC approach (Figure 5). On the other hand, the
lack of power of HD-NPC and HD to detect low levels
of asymmetry is compensated by the fact that, without
any a priori assumptions regarding mating symmetry, both
methods maintained low type I error rates, at least under the
simulation conditions presented here (Figure 4).
Therefore if asymmetry is not strong enough to be
detected by the MA test it should not be falsely interpretedJournal of Biomedicine and Biotechnology 9
Table 5:DistributionofCDKN2Ars36228834andCDKN2Brs36229158genotypesandassociatedriskestimatesforpre-BALLsusceptibility
among children.
Gene, DNA variant, No. (%) Log-linear regression analysis
and genotype ALL
patients
ALL
mothers
ALL
fathers Controls Model Genotype Child OR (95% CI) P
CDKN2A
rs36228834 Child versus
Null TA versus TT 2.48 (1.45–4.15) .001
TT 266 (86.6) 160 (93.0) 149 (86.6) 298 (93.7) AA versus TT 9.87 (0.89–109.69)
TA 39 (12.7) 12 (7.0) 22 (12.8) 19 (6.0) TA/AA versus TT 2.56 (1.54–4.26) <.0005
AA 2 (0.7) 0 1 (0.6) 1 (0.3) Child + Mother
versus Null TA versus TT 3.13 (1.81–5.40) <.0005
AA versus TT —
TA/AA versus TT 2.56 (1.54–4.26) <.0005
CDKN2B
rs36229158 Child versus
Null CT versus CC 1.77 (0.98–3.21) .054
CC 277 (91.4) 164 (95.4) 155 (90.1) 302 (94.7) TT versus CC 8.25 (0.75–91.3)
CT 24 (7.9) 8 (4.6) 16 (9.3) 16 (5.0) CT/TT versus CC 1.86 (1.04–3.34) .037
TT 2 (0.7) 0 1 (0.6) 1 (0.3) Child + Mother
versus Null CT versus CC 2.32 (1.23–4.35) .033
TT versus CC —
CT/TT versus CC 2.44 (1.29–4.60) .006
Percentages indicate number of individuals with a given genotype/total number of genotyped individuals. Risk estimation was performed using log-linear
regression analysis as implemented in the LEM software. Child odd ratios were measured using regression models consisting of the child genotype eﬀect only
(Child versus Null) or both child and mother genotypes (Child + Mother versus Null). Mating symmetry (i.e., six mating-type parameters) was assumed at
both loci. P values of the Wald test provided by LEM are shown for either the 2 degree-of-freedom (2 child genotype eﬀects) or 1 degree-of-freedom (1 child
genotype eﬀect resulting from the collapsed heterozygous/homozygous rare genotypes) tests. OR indicates odds ratio; CI: conﬁdence interval.
as a maternally-mediated eﬀect. By contrast if a maternal
eﬀect is present and HD-NPC is used to test for mating
asymmetry without parents of controls, type I error rates
(of false detection of MA) are high (ranging from 0.8 to
0.9 for MAFs of 0.10 to 0.25, resp.) leading to a subsequent
loss of power to detect maternal eﬀects due to the over-
parameterisation under the MA models (data not shown).
Together these results show that the log-linear, likelihood-
basedstepwiseprocedureusingunaﬀectedoﬀspringprovides
a valid framework to evaluate MS without leading to spu-
rious maternal associations. And when parents of controls
cannot be ascertained but an additional set of unrelated
controls is available, one can safely use this approach to test
for fetomaternal associations if willing to accept that certain
confounded maternally-mediated eﬀects may be missed
when parental mating is asymmetric.
3.2. Fetomaternal Association Study of Childhood Acute
Lymphoblastic Leukemia. Guided by our simulation results
we went on to test for fetomaternal associations between
29 SNPs in the proximal promoter regions of 12 cell-cycle
genes [29] and the susceptibility to childhood pre-B ALL.
SNP frequencies were in agreement with those previously
reported in other populations of European descent and
all distributions were in Hardy-Weinberg equilibrium. Our
dataset consisted of 118 pre-B ALL patients, 203 ALL case-
parent triads, and 329 unrelated controls. The lack of parents
of controls prevents us from excluding MA in the source
population. Based on the results from our simulation study,
we used the log-linear framework to perform likelihood-
based testing in a stepwise fashion. For each SNP, we per-
formed a three degree-of-freedom likelihood-ratio test for
asymmetryimplementedintheLEMsoftwareusingaslightly
less stringent P value <. 1 0t or e j e c ts y m m e t r yi no r d e rt o
reduce false-positives in the tests for maternal eﬀects. Under
this threshold, we identiﬁed MA at variants rs1144944 (P =
.086)andrs3730485 (P = .095)of the MDM2gene,aswellas
at CDKN2B variant rs2069416 (P = .076); we did not detect
asymmetry at any of the remaining loci tested (P values >.10;
data not shown). Consequently, MA models (nine mating-
type parameters) were used to test for association at these
threeSNPswhereasMSmodels(sixmating-typeparameters)
were used for the remaining 26 SNPs (see Figure 6, for the
Child and Mother single-step test results and Supplementary
Table 1 for complete likelihood-ratio chi-square test results).
Nominally signiﬁcant genotype associations at the level of
the child were identiﬁed for CDKN2A rs36228834 (Child
versus Null; P = .0007), CDKN1B rs35756741 (Child
versus Null; P = .0235) and CDKN2B rs2069416 (Child
versus Null; P= 0.0063); however only CDKN2A rs36228834
and CDKN2B rs2069416 remained signiﬁcant after multi-
ple testing corrections (Supplementary Table 1). None of
the other 26 loci revealed any signiﬁcant child-mediated
genetic associations with ALL and no signiﬁcant maternal10 Journal of Biomedicine and Biotechnology
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Figure 6: Log-linear, likelihood-ratio association analysis between 29 regulatory SNPs from 12 cell-cycle genes and childhood pre-B acute
lymphoblastic leukemia (ALL). Log-linear regression analysis was performed in LEM using 203 case-triads, 118 unrelated ALL patients and
329 controls. Results of the likelihood-ratio chi-square tests (− log P) are shown for the single-step Child (blue) and Mother (red) tests.
Mating symmetry (i.e., six mating-type parameters) was assumed at all loci but variants rs1144944 and rs3730485 of the MDM2 gene, as
well as CDKN2B rs2069416 for which MA models (nine mating-type parameters) were used to test for association. Horizontal reference line
indicates P value of .05. Note that for the tri-allelic variant CDKN2B rs2069416 (A > T,C) individuals were grouped according to their T
allele such that
∗∗ >
∗T > TT. See Supplementary Table 1 for complete likelihood-ratio chi-square test results.
genotype eﬀects were identiﬁed through the Mother ver-
sus Null log-linear test (Figure 6 and Supplementary
Table 1).
Nominally signiﬁcant SNPs were further analyzed to
detect putative joint fetomaternal eﬀects. After accounting
for the eﬀect of the child’s genotype, we found a signiﬁcant
maternal association at CDKN2A rs36228834 (Child +
Mother versus Child; P = .0168) only (Supplementary
Table 1). The CDKN2A rs36228834 A allele was overrepre-
sented in patients when compared with controls (genotype
Fisher’s exact P = .005) and carriers of the A risk allele
were 2.5-fold more susceptible to ALL (Child versus Null;
TA versus TT: OR = 2.48; 95%CI (1.45–4.15); TA/AA versus
TT: OR = 2.56; 95%CI (1.54–4.26)). This risk was further
increased when the mother’s genotype was included in
the model (Child + Mother versus Null; TA versus TT:
OR = 3.13; 95%CI (1.81–5.40); TA/AA versus TT: OR =
3.20; 95%CI (1.85–5.53)) (Table 5). No further maternal
association was detected for CDKN1B rs35756741 (Child +
Mother versus Child; P = .59) or CDKN2B rs2069416 (Child
+ Mother versus Child; P = .33) (Supplementary Table 1).
These results provide evidence of a novel fetomaternal
eﬀect at the CDKN2A rs36228834 locus that may inﬂuence
pre-B ALL susceptibility among children, and a possible
joint eﬀect of both mother and child genotypes without
main eﬀects at CDKN2B rs36229158. Interestingly, although
variant CDKN2B rs36229158 presented only a suggestive
eﬀect at the level of the child (Child versus Null; P = .06),
a signiﬁcant association was found for the mother after we
accounted for the genotype of the child (Child + Mother
versus Child; P = .0217) (Supplementary Table 1). Including
the mother’s genotype in the regression model signiﬁcantly
increased the risk 2.3-fold for carriers of a C allele (Child
+ Mother versus Null; CT versus CC: OR = 2.32; 95%CI
(1.23–4.35); CT versus CC: OR = 2.44; 95%CI (1.29–4.60))
(Table 5).
Independent replication is required in order to conﬁrm
the signiﬁcance of these associations given that some of
these variants did not withstand multiple testing correction
(CDKN1B rs35756741 and CDKN2B rs36229158); and cau-
tion is warranted in the interpretation of the risk estimates
as risk allele frequencies at loci CDKN2A rs36228834 andJournal of Biomedicine and Biotechnology 11
CDKN2Brs36229158werelow(MAFs ≤0.05),yieldinglarge
conﬁdence intervals, particularly for the rare homozygous
genotype classes. We also recognize that the interpretation
of our real-data results relies in part on our simulation
results and there are certain limitations to our simulation
study. These include the restricted number of models used
in the method evaluations and the important assumptions
of absence of population substructure and Hardy-Weinberg
equilibrium, which necessitate further investigation. Our
conclusions on the validity of the HD-NPC approach under
MAshouldholdforothermodels.Aswenoted,thedetection
of asymmetry and maternal eﬀects are partially confounded
with HD-NPC and it is diﬃcult to imagine a model of
asymmetry for which diﬀerences in mating type frequencies
would not be detected by the asymmetry test but would
be captured by the Mother versus Null test, thus leading
to increased type I error. However, the reduction in power
of HD-NPC compared to HD will likely be aﬀected by the
underlying genetic and asymmetry models and should be
assessed under a wider range of models. Other important
genetic eﬀects should also be investigated, such as mother-
gene child-gene interactions and parent-of-origin eﬀects
which are not addressed here but can also be involved in
early-onset disorder risk.
Nonetheless, our results provide evidence that genes that
regulate the cell cycle could play an important role during
fetal development when the rate of cell growth and division
is high both in child and mother. In silico analysis using the
Match software [37] revealed that all three variant loci lead
to the disruption of putative transcription factor binding
sites, including the loss of binding sites for FOS and MYB at
CDKN2Ars36228834. TheFOSoncoproteinstimulates tran-
scription of genes containing AP-1 regulatory elements and
may transform cells through alterations in DNA methylation
and in histone deacetylation [38]. Expression of FOS is 100-
fold greater in human fetal membranes than in other normal
humantissuesandcells[39].TheMYBtranscriptionfactoris
essentialforhematopoiesisandcontrolstheproliferationand
diﬀerentiation of hematopoietic stem and progenitor cells
[40]. MYB is frequently involved in hematopoietic disorders
including ALL [41]. Although the biological relevance of our
ﬁndings remains to be elucidated, our study suggests that
promoter variation in the cell-cycle inhibitor gene CDKN2A,
and possibly CDKN2B, could disrupt transcription-factor
binding and inﬂuence gene expression during gestation.
Disregulated cell division caused by aberrant cell-cycle
inhibitor gene expression in both mother and child could
disrupt the maternal-fetal interface and aﬀect important
physiologicalprocessessuchasthegrowthofthefetusand/or
normal haematopoiesis and potentially lead to increased
susceptibility to ALL.
4. Conclusions
Given the unique nature of childhood disorders, the inves-
tigation of parental genetics and maternally-contributed
eﬀects is a prerequisite not only for understanding disease
etiologybutalsotopavethewaytowardnewopportunitiesin
preventive medicine. Although the most powerful approach
is ideally the most desirable, in practice the best approach
might be one that combines both valid detection of the pos-
sible underlying genetic associations involved in early-onset
disorders and a feasible design in terms of ascertainment
and genotyping costs. We have shown that the log-linear,
likelihood-based framework using a case-triad/case-control
design retains the ability to control for bias due to MA and
can provide valid tests for maternally-contributed genotype
eﬀects even when the assumption of symmetry fails. Despite
a modest sample size, we successfully used this approach to
identify putative fetomaternal genotype eﬀects in cell-cycle
inhibitor genes CDKN2A and CDKN2B that are associated
with modiﬁed risks of childhood pre-B ALL. Although these
geneshavebeenpreviouslyassociatedwithALL[28],wehave
shown for the ﬁrst time that their inﬂuence on ALL risk
might be driven, in part, by the maternal genotype. This
study provides the ﬁrst indication that maternal genotype
eﬀects can inﬂuence the risk of developing pediatric ALL,
providingusefulinsightsintothegeneticmechanismsunder-
lying this early-onset disease.
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